Thread by @nicolamlow

@nataliexdean @EpiEllie Ooh, yes. You should judge risk of bias in #LivingSystematicReviews as you would a standard one. @jhjelliott says, „We propose living systematic review as a contribution to evidence synthesis that combines currency with rigour“ journals.plos.org/plosmedicine/a… 1/n

@nataliexdean @EpiEllie @jhjelliott Julian Elliott really started the movement with a project in @cochranecollab community.cochrane.org/review-product… and followed up with a series in J Clin Epidemiol (pt1 here sciencedirect.com/science/articl…) 2/n

@nataliexdean @EpiEllie @jhjelliott @cochranecollab Most #LivingSystematicReviews are geared towards evaluating treatments. If you want to look at observational study examples, we have #Asymptomatic #SARSCoV2, which is quite popular

https://twitter.com/plosmedicine/status/1313538630774927364?s=12

@dianacarbg @MichelDVM @DianneEgliGany @Geointheworld and 3/n

https://twitter.com/PLOSMedicine/status/1313538630774927364

@nataliexdean @EpiEllie @jhjelliott @cochranecollab #Zika assessment of causality of #Microcephaly #GuillainBarreSyndrome journals.plos.org/plosmedicine/a… @FabiKrauer @broutet_n and sexual transmission journals.plos.org/plosmedicine/a… 4/n

@nataliexdean @EpiEllie @jhjelliott @cochranecollab @dianacarbg @MichelDVM @DianneEgliGany @Geointheworld Also, #LivingSystematicReviews in methodology, on prediction models for #COVID19 @maartenvsmeden @laure_wynants bmj.com/content/369/bm… Important to look for the protocols for methods and risk of bias assessment. In short, pls include in reviews of reviews 5/5

@nataliexdean @EpiEllie @jhjelliott @cochranecollab @dianacarbg @MichelDVM @DianneEgliGany @Geointheworld @MaartenvSmeden @laure_wynants @threadreaderapp please unroll